Jules Lin, MD
Dr. Jules Lin is a noted thoracic and surgical critical care surgeon at the University of Michigan and Rogel Cancer Center, where his areas of practice include minimally invasive and robotic surgery for the treatment of patients with lung and esophageal cancer, malignant pleural mesothelioma, and other chest wall and thoracic malignancies.[1]
Dr. Lin has technical expertise in tracheal resection, VATS lobectomies, thoracoscopy, Sympathectomy, lung transplantation, and robotic-assisted thoracic surgery.
Education and Career
Dr. Lin began his educational journey at Indiana University at Bloomington, earning a bachelor’s degree in Chemistry, Biology, and East Asian Studies as a Phi Beta Kappa graduate. He earned his medical degree at Harvard Medical School and then completed an internship and residencies in General Surgery and Surgical Critical Care at the University of Michigan. While at Michigan, he also completed a research fellowship in the Thoracic Surgery Tumor Biology Laboratory. He then completed a Cardiothoracic Surgery residency at the University of Washington.[1]
Since returning to the University of Michigan and Rogel Cancer Center, he has taken on the roles of Professor in the Section of Thoracic Surgery, Surgical Director of the Lung Transplant Program, Mark B. Orringer Research Professor, and Associate Chief Clinical Officer of CV/Neuro.
Professional Organizations
Dr. Lin is a member of several notable professional organizations, including:[1]
- American Association for Cancer Research, Associate Member to American Association for Cancer Research, Member
- American Association for Thoracic Surgery, Member
- American College of Surgeons, Fellow
- CHEST, Member
- General Thoracic Surgical Club, Member
- Henry N. Harkins Surgical Society to Henry N. Harkins Surgical Society
- International Society of Heart and Lung Transplantation, Member
- John Alexander Society, Member to John Alexander Society, Member
- Society of Thoracic Surgeons, Member
- Western Thoracic Surgical Association, Member
Research Interests
Dr. Lin’s research centers on the molecular changes involved in the pathogenesis of thoracic malignancies. As a member of the University of Michigan Rogel Cancer Center’s Thoracic Tumor Biology Laboratory, he is working towards moving the results of his investigations into tailored therapies for patients with tumors expressing specific molecular targets and discovering novel diagnostic, staging, and treatment modalities. He has already identified several novel molecular changes involved in the pathogenesis of esophageal adenocarcinoma and is currently investigating potential targets in the treatment and prevention of metastatic disease, as well as the modulation of chemoresistance.[1]
Dr. Lin has co-authored over 255 articles in respected medical journals, including those listed below.
- Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology, September 2023, Journal of the National Comprehensive Cancer Network: JNCCN 21(9):961-979, DOI:10.6004/jnccn.2023.0045
- Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology, September 2023, Journal of the National Comprehensive Cancer Network: JNCCN 21(9):961-979, DOI:10.6004/jnccn.2023.0045
- A Year in General Thoracic Surgery at the Journal of Thoracic and Cardiovascular Surgery: 2020, April 2021, Journal of Thoracic and Cardiovascular Surgery162(Suppl 2), DOI:10.1016/j.jtcvs.2021.03.106
